ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma.

[1]  M. Trněný,et al.  Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: a retrospective study. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  J. C. Meneghetti,et al.  Cost effectiveness of positron emission tomography in patients with Hodgkin's lymphoma in unconfirmed complete remission or partial remission after first-line therapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  R. Advani,et al.  Role of FDG-PET/CT Surveillance for Patients with Classical Hodgkin's Disease in First Complete Response: The Stanford University Experience. , 2009 .

[4]  A. Zelenetz,et al.  Impact of Routine Surveillance Imaging on the Outcome of Patients with Relapsed Hodgkin Lymphoma. , 2009 .

[5]  A. Ng,et al.  Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Broeks,et al.  Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  L. Robison,et al.  Radiation dose and breast cancer risk in the childhood cancer survivor study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. D. De Bruin,et al.  Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. , 2009, Journal of the National Cancer Institute.

[9]  A. Ng,et al.  Late Effects of Hodgkin’s Disease and Its Treatment , 2009, Cancer journal.

[10]  D. Neuberg,et al.  A prospective study of pulmonary function in Hodgkin's lymphoma patients. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  D. Plewes,et al.  Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer , 2008, Annals of Internal Medicine.

[12]  A. LaCasce,et al.  High False Positive Rate with the Use of CT and FDG-PET in Post-Remission Surveillance for Hodgkin Lymphoma. , 2007 .

[13]  B. Cheson.  The International Harmonization Project for response criteria in lymphoma clinical trials. , 2007, Hematology/oncology clinics of North America.

[14]  M. Somerfield,et al.  American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  P. Hall,et al.  Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. Tsang,et al.  Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy , 2007, Hematological oncology.

[17]  A. Hart,et al.  Late cardiotoxicity after treatment for Hodgkin lymphoma. , 2007, Blood.

[18]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[19]  V. Diehl,et al.  Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  C. Andreadis,et al.  Detection of Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin’s Lymphoma (HL): Observations and Implications for Post-Remission Radiologic Surveillance. , 2006 .

[21]  P. Das,et al.  Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  S. Hancock,et al.  Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  S. Hancock,et al.  Diastolic dysfunction after mediastinal irradiation. , 2005, American heart journal.

[24]  V. Diehl,et al.  Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  R. Tsang,et al.  Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma. , 2005, International journal of radiation oncology, biology, physics.

[26]  Yan Liu,et al.  Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  V. Diehl,et al.  Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long‐term survivors of Hodgkin's disease: July 9–16, 2003, Bellagio, Italy , 2005, European journal of haematology. Supplementum.

[28]  S. Lipsitz,et al.  Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  C. Pepine,et al.  Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. , 2003, JAMA.

[30]  S. Hancock,et al.  Asymptomatic cardiac disease following mediastinal irradiation. , 2003, Journal of the American College of Cardiology.

[31]  H. Jernström,et al.  Follow-up of patients with Hodgkin's disease following curative treatment: the routine CT scan is of little value , 2003, British Journal of Cancer.

[32]  M. Stovall,et al.  Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. , 2003, JAMA.

[33]  A. Broeks,et al.  Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. , 2003, Journal of the National Cancer Institute.

[34]  P. Mikosch,et al.  Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphoma. , 2003, Acta medica Austriaca.

[35]  J. Friedberg,et al.  Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. , 2002, Blood.

[36]  D. Neuberg,et al.  Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  John D Boice,et al.  Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. , 2002, Journal of the National Cancer Institute.

[38]  S. Kaasa,et al.  Late medical complications and fatigue in Hodgkin's disease survivors. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  M. Williams,et al.  Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  F. Maul,et al.  Whole body positron emission tomography in the treatment of Hodgkin disease , 2001, Cancer.

[41]  D. Green,et al.  Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. , 2000, The Journal of clinical endocrinology and metabolism.

[42]  I. Lax,et al.  Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[43]  S. Jeffrey,et al.  Management of breast cancer after Hodgkin's disease. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  T. Lister,et al.  Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  P. Parikh,et al.  Gonadal function following ABVD therapy for Hodgkin's disease. , 1997, American journal of clinical oncology.

[46]  J. Poen,et al.  Detection of relapse in early-stage Hodgkin's disease: role of routine follow-up studies. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  P. Domingo,et al.  Duplication of surgical research presentations , 1997, BMJ.

[48]  D. Leung,et al.  Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  A. Hagenbeek,et al.  Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. , 1995, Journal of the National Cancer Institute.

[50]  R. Olshen,et al.  Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  S L Hancock,et al.  Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. , 1993, JAMA.

[52]  D. Dershaw,et al.  Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  S. Hancock,et al.  Thyroid diseases after treatment of Hodgkin's disease. , 1991, The New England journal of medicine.

[54]  N. Tarbell,et al.  Thoracic irradiation in Hodgkin's disease: disease control and long-term complications. , 1990, International journal of radiation oncology, biology, physics.

[55]  S. Pileri,et al.  Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma , 2009 .

[56]  V. Diehl,et al.  Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG). , 2008, Blood.

[57]  D. Ikeda,et al.  Mammographic Screening in Women at Increased Risk of Breast Cancer after Treatment of Hodgkin’s Disease , 2008, The breast journal.

[58]  P. Goss,et al.  Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[59]  A. Ng,et al.  Cost-Effectiveness Analysis of Computerized Tomography in the Routine Follow-Up of Patients After Primary Treatment for Hodgkin's Disease , 2007 .

[60]  R. Hustinx,et al.  Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[61]  R. Hoppe.  Hodgkin's disease: complications of therapy and excess mortality. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[62]  R. Jenni,et al.  Cardiac lesions after mediastinal irradiation for Hodgkin's disease. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.